GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway

We previously demonstrated that treatment of the H295R adrenocortical cancer cell line with the non-steroidal, high-affinity GPER (G protein-coupled estrogen receptor 1) agonist G-1 reduced tumor growth in vitro and in vivo through a GPER independent action. Moreover, we observed that G-1 treatment...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Casaburi, Ivan, Avena, Paola, De Luca, Arianna, Sirianni, Rosa, Rago, Vittoria, Chimento, Adele, Trotta, Francesca, Campana, Carmela, Rainey, William E., Pezzi, Vincenzo
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777797/
https://ncbi.nlm.nih.gov/pubmed/29383185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23314
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars